Doximity, Inc. (DOCS) saw its stock surge 10.15% in a 24-hour period, driven by impressive first-quarter results for fiscal 2026, an optimistic future outlook, and news of a strategic acquisition. The digital platform for medical professionals demonstrated robust performance, exceeding analyst expectations across key financial metrics.

In its fiscal Q1 report, Doximity posted adjusted earnings per share of $0.36, surpassing the analyst consensus estimate of $0.30 by 20% and marking a 28.57% increase from the same period last year. Revenue for the quarter reached $145.913 million, beating the expected $139.705 million by 4.44% and representing a 15.19% year-over-year growth. The company's adjusted EBITDA also impressed at $79.8 million, significantly outperforming the estimated $71.6 million.

Adding to investor enthusiasm, Doximity provided an upbeat forecast for both the second quarter and the full fiscal year 2026. The company projects Q2 revenue between $157 million and $158 million, well above the consensus estimate of $150.35 million. For the full fiscal year, Doximity raised its revenue guidance to $628 million - $636 million, surpassing analysts' expectations of $626.47 million. Furthermore, the company announced its acquisition of Pathway for $63 million, a strategic move that could potentially enhance its service offerings and strengthen its market position in the healthcare technology sector.